It is a research & development private limited company based in Bangalore, Karnataka, India, established in 2018.
2018 | Bangalore, Karnataka, India | ActiveAvanclin Private Limited, a active private limited company, was established on 09 March 2018 in Bangalore, Karnataka, India. Engaging in science research within the research & development sector, it holds CIN: U73100KA2018PTC110917. Registered under ROC Roc Bangalore. it is unlisted. It has an authorized capital of ₹1.00 M and a paid-up capital of ₹0.10 M.
Its leadership includes Viswanadhareddy Penugonda (Director), Suvarna Venkata Anakala (Director). Past directors included Suresh Kumar Venkata Gorentla, Anakala Revantha Reddy, Revanth Bingumalla. Its latest AGM occurred on 28 December 2020, with the balance sheet filed on 31 March 2020. It is based at # 480/13-1, 7Th Cross, Mahalakshmi Layout, Bangalore, Karnataka, 560086.
U73100KA2018PTC110917
110917
09 March 2018
₹1.00 M
₹0.10 M
Roc Bangalore
Unlisted
Active
Explore comprehensive insights into Avanclin Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Viswanadhareddy Penugonda | Director | 24 Jul 2019 | Current |
| Suvarna Venkata Anakala | Director | 24 Jul 2019 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 24 Jul 2019 | Past |
| Pramod Abcsdd | Director | 24 Jul 2019 | Past |
| Pramod Abcsdd | Director | 24 Jul 2019 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Avanclin Private Limited, for the financial year ended 2020, experienced no change in revenue, with a 0% increase. The company also saw a substantial fall in profitability, with a 562.74% decrease in profit. The company's net worth observed a substantial decline by a decrease of 994.85%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
Unlock access to Avanclin's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Reveal ownership structures and financial performance - Get instant access now!
There are no open charges registered against the company as per our records.
Unlock and access historical data on people associated with Avanclin, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Avanclin, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Avanclin's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Avanclin Private Limited last Annual general meeting of members was held on 28 Dec 2020 as per latest MCA records. was recorded as a recent event.
Progress on Avanclin Private Limited has filed its annual Financial statements for the year ended 31 Mar 2020 with Roc Bangalore. was documented.
Progress on Viswanadhareddy Penugonda was appointed as a Director was appointed as a Director on 24 Jul 2019 & has been associated with this company since 6 years 4 months . was documented.
Suvarna Venkata Anakala was appointed as a Director was appointed as a Director on 24 Jul 2019 & has been associated with this company since 6 years 4 months . was recorded as a recent event.
Avanclin Private Limited was registered on 09 Mar 2018 with Roc Bangalore & aged 7 years 9 months as per MCA records. was recorded as a recent event.
The CIN of Avanclin Private Limited is U73100KA2018PTC110917.
Avanclin Private Limited is headquartered at # 480/13-1, 7Th Cross, Mahalakshmi Layout, Bangalore, Karnataka, 560086.
Avanclin Private Limited was incorporated on 09 March 2018.
The current directors of Avanclin Private Limited are
The primary industry of Avanclin Private Limited is Research & Development.
Avanclin Private Limited is unlisted.
The authorized capital of Avanclin Private Limited is ₹1.00 M, and the paid-up capital is ₹0.10 M.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX